Alan O - Search Results

1

How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.

Alan O, Kuzhan O, Koca S, Telli TA, Basoglu T, Ercelep O, Filinte D, Sengul Y, Arikan H, Kaya S, Babacan NA, Dane F, Yumuk PF. Alan O, et al. J Oncol Pharm Pract. 2020 Jun;26(4):1011-1018. doi: 10.1177/1078155219879757. Epub 2019 Oct 15. J Oncol Pharm Pract. 2020. PMID: 31615346 Review.

2

Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer.

Kaya S, Aktas B, Tanrikulu Sismek E, Akif Ozturk M, Dede F, Kaya H, Ugurlu U, Ozgen Z, Koca S, Halil S, Hasanov R, Alan O, Akgul Babacan N, Ercelep O, Dane F, Gumus M, Yumuk F. Kaya S, et al. Among authors: alan o. J BUON. 2017 Sep-Oct;22(5):1191-1198. J BUON. 2017. PMID: 29135102 Free article.

3

A case of primary squamous cell carcinoma of the breast with pathologic complete response after neoadjuvant chemotherapy.

Alan O, Telli TA, Ercelep O, Hasanov R, Simsek ET, Mutis A, Ones T, Kaya H, Yumuk PF. Alan O, et al. Curr Probl Cancer. 2019 Aug;43(4):308-311. doi: 10.1016/j.currproblcancer.2018.04.003. Epub 2018 May 9. Curr Probl Cancer. 2019. PMID: 29880396

4

Chordoma: a case series and review of the literature.

Alan O, Akin Telli T, Ercelep O, Tanrikulu Simsek E, Basoglu Tuylu T, Mutis A, Hasanov R, Kaya S, Akgül Babacan N, Dane F, Yumuk PF. Alan O, et al. J Med Case Rep. 2018 Aug 27;12(1):239. doi: 10.1186/s13256-018-1784-y. J Med Case Rep. 2018. PMID: 30145982 Free PMC article. Review.

5

Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer.

Ercelep O, Alan O, Sahin D, Telli TA, Salva H, Tuylu TB, Babacan NA, Kaya S, Dane F, Ones T, Alkis H, Adli M, Yumuk F. Ercelep O, et al. Among authors: alan o. Clin Transl Oncol. 2019 Apr;21(4):499-504. doi: 10.1007/s12094-018-1949-6. Epub 2018 Sep 18. Clin Transl Oncol. 2019. PMID: 30229391

6

A rare case of primary rectal choriocarcinoma and review of the literature.

Telli TA, Demircan NC, Alan O, Tuylu TB, Arikan R, Ercelep O, Atıcı AE, Ergelen R, Seven IE, Babacan NA, Kaya S, Dane F, Fulden Yumuk P. Telli TA, et al. Among authors: alan o. J Oncol Pharm Pract. 2020 Jun;26(4):989-994. doi: 10.1177/1078155219875510. Epub 2019 Sep 23. J Oncol Pharm Pract. 2020. PMID: 31547751 Review.

7

Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy.

Demircan NC, Dane F, Ozturk MA, Babacan NA, Besiroglu M, Kaya S, Ercelep O, Tanrikulu E, Halil S, Koca S, Alan O, Hasanov R, Yumuk PF. Demircan NC, et al. Among authors: alan o. J BUON. 2019 Jul-Aug;24(4):1494-1500. J BUON. 2019. PMID: 31646797 Free article.

8

Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib.

Demircan NC, Alan Ö, Başoğlu Tüylü T, Akın Telli T, Arıkan R, Çiçek FC, Ercelep Ö, Öztürk MA, Alsan Çetin İ, Ergelen R, Tinay İ, Akgül Babacan N, Kaya S, Dane F, Yumuk PF. Demircan NC, et al. Among authors: alan o. J Oncol Pharm Pract. 2020 Jul;26(5):1147-1155. doi: 10.1177/1078155219890032. Epub 2019 Dec 2. J Oncol Pharm Pract. 2020. PMID: 31793376

9

VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature.

Telli TA, Okten IN, Tuylu TB, Demircan NC, Arikan R, Alan O, Ercelep O, Ones T, Yildirim AT, Dane F, Yumuk PF. Telli TA, et al. Among authors: alan o. Curr Probl Cancer. 2020 Oct;44(5):100568. doi: 10.1016/j.currproblcancer.2020.100568. Epub 2020 Mar 14. Curr Probl Cancer. 2020. PMID: 32201052 Review.

10

Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy.

Akkiprik M, Koca S, Uğurlu MÜ, Ekren R, Peker Eyüboğlu İ, Alan Ö, Erzik C, Güllü Amuran G, Telli TA, Güllüoğlu MB, Sezerman U, Yumuk PF. Akkiprik M, et al. Among authors: alan o. Clin Breast Cancer. 2020 Aug;20(4):332-343.e3. doi: 10.1016/j.clbc.2020.02.006. Epub 2020 Feb 26. Clin Breast Cancer. 2020. PMID: 32201164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters